Congenital infections

Neurologic Clinics

Volumn 20, Issue 4, 2002, Pages 1039-1060

  Bale Jr , James F ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYTOMEGALOVIRUS VACCINE; FOLINIC ACID; GANCICLOVIR; HERPES ZOSTER IMMUNOGLOBULIN; PENICILLIN DERIVATIVE; PYRIMETHAMINE; RUBELLA VACCINE; SPIRAMYCIN; SULFADIAZINE;

BEHAVIOR DISORDER; CHICKENPOX; CONGENITAL INFECTION; CONGENITAL RUBELLA SYNDROME; CONGENITAL SYPHILIS; CONGENITAL TOXOPLASMOSIS; CYTOMEGALOVIRUS INFECTION; HEARING IMPAIRMENT; HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; INTRAUTERINE INFECTION; MALARIA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; VARICELLA ZOSTER VIRUS; VISUAL IMPAIRMENT;

BRAIN; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS; PREGNANCY; PREGNANCY COMPLICATIONS; RUBELLA; SYPHILIS; TOMOGRAPHY, X-RAY COMPUTED; TOXOPLASMOSIS, CONGENITAL; VIRUS DISEASES;

EID: 0036829877     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(02)00014-2     Document Type: Review

References (108)

1. Nahmias AJ. The TORCH complex. Hosp Pract 1974;May:65-72.
2. Demmler GJ. Summary of a workshop on surveillance of congenital cytomegalovirus disease. Rev Infect Dis 1991;13:315-29.
3. Bale JF, Jr, Jordan MC. Cytomegalovirus. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of Clinical Neurology, Vol. 12. Viral Disease. Amsterdam: Elsevier; 1989. p. 263-79.
4. Britt WJ, Alford CA. Cytomegalovirus. In: Fields BN, Knipe DM, Howley JM, Fields Virology. 3rd Edition. Philadelphia: Lippincott-Raven; 1996. p. 2493-523.
5. Pass RF, August AM, Dworsky M, et al. Cytomegalovirus infection in a day care center. N Engl J Med 1982;307:477-9.
6. Pass RF, Hutto C, Ricks R, et al. Increased rate of cytomegalovirus infection among parents of children attending day care centers. N Engl J Med 1986;314:366-70.
7. Adler SP. Cytomegalovirus and child day care: Evidence for an increased infection rate among day care workers. N Engl J Med 1989;321:1290-6.
8. Murph JR, Baron JC, Brown CK, et al. The occupational risk of cytomegalovirus among day care providers. JAMA 1991;265:603-8.
9. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy: Incidence, transmission to fetus, and clinical outcome. JAMA 1986;256:1904-8.
10. Bale JF, Jr, Petheram SJ, Souza IE, Murph JA. Cytomegalovirus reinfection in children. J Pediatr 1996;128:347-52.
11. Boppana SB, Rivera LB, Fowler KB, et al. Intrauterine transmission of cytomegalovirus to infants of mothers with preconceptional immunity. N Engl J Med 2001;344:1366-71.
12. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992;14:608-15.
13. Istas AS, Demmler GJ, Dobbins JG, Stewart JA. Surveillance for congenital cytomegalovirus disease: A report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis 1995;20:665-70.
14. Boppana SB, Pass RF, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Pediatr Infect Dis J 1992;11:93-9.
15. Lazzarotto T, Varani S, Gabrielli L, et al. New advances in the diagnosis of congenital cytomegalovirus infection. Intervirology 1999;42:390-7.
16. Lazzarotto T, Varani S, Guerra B, et al. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000;137:90-5.
17. Enders G, Bader U, Lindemann L, et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001;21:362-77.
18. Noyola DE, Demmler GJ, Nelson CT, et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2001;138:325-31.
19. Boppana SB, Fowler KB, Vaid Y, et al. Neuroradiographic findings in the newborn period and long term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997;99:409-14.
20. Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial. Pediatr Infect Dis J 1996;15:240-6.
21. Pass RF, Stagno S, Meyers GJ, et al. Outcome of symptomatic congenital cytomegalovirus infection: Results of long-term, longitudinal follow-up. Pediatrics 1980;66:758-62.
22. Kimberlin DW, Lin CY, Sanchez P, et al. Ganciclovir (GCV) treatment of symptomatic congenital cytomegalovirus (CMV) infection: Results of a phase III randomized trial [abstract 1942]. Presented at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, Canada, September, 17-20, 2000.
23. Hocker J, Cook L, Adams G, et al. Ganciclovir therapy of congenital cytomegalovirus pneumonia. Pediatr Infect Dis J 1990;9:743-5.
24. Whitley RJ, Cloud G, Gruber W, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study. J Infect Dis 1996;175:1080-6.
25. Pass RF, Duliege AM, Boppana S, et al. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis 1999;180:970-5.
26. Plotkin SA. Vaccination against cytomegalovirus. Arch Virol Suppl 2001;17:121-34.
27. Dahle AJ, Fowler KB, Wright JD, et al. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000;11:283-90.
28. Koskiniemi M, Lappalainen M, Hedman K. Toxoplasmosis needs evaluation: An overview and proposals. Am J Dis Child 1989;143:724-8.
29. Baril L, Ancelle T, Goulet V, et al. Risk factors for Toxoplasma infection in pregnancy: A case control study in France. Scand J Infect Dis 1999;31:305-8.
30. Jones JL, Kruszon-Moran D, Wilson D, et al. Toxoplasma gondii infection in the United States: Seroprevalence and risk factors. Am J Epidemiol 2001;154:352-65.
31. Jeannel D, Niel G, Costagliola D, et al. Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol 1988;17:595-602.
32. Evengard B, Petersson K, Engman ML, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001;127:121-7.
33. Couvreur J. Problems of congenital toxoplasmosis: Evolution over four decades. Presse Med 1999;28:753-7.
34. Ambroise-Thomas P, Schweitzer M, Pinon JM, et al. Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up. Bull Acad Natl Med 2001;185:665-83.
35. Mara M, Hsu HW, Eaton RB, et al. Epidemiology of congenital toxoplasmosis identified by population-based newborn screening in Massachusetts. Pediatr Infect Dis J 2001;20:1132-5.
36. Couvreur J, Desmonts G. Congenital and maternal toxoplasmosis. Dev Med Child Neurol 1962;4:519-30.
37. Roizen N, Swisher C, Stein M, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995;95:11-20.
38. Swisher C, Boyer K, McLeod R. Congenital toxoplasmosis. Semin Pediatr Neurol 1994;1:4-25.
39. Mitchell CD, Erlich SS, Mastrucci MT, et al. Congenital toxoplasmosis occurring in infants perinatally infection with human immunodeficiency virus 1. Pediatr Infect Dis J 1990;9:512-8.
40. Boyer KM. Diagnostic testing for congenital toxoplasmosis. Pediatr Infect Dis J 2001;20:59-60.
41. Naessens A, Jenum PA, Pollak A, et al. Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation. J Pediatr 1999;135:714-9.
42. Johnson J, Butcher P, Savva D, et al. Application of the polymerase chain reaction to the diagnosis of human toxoplasmosis. J Infect 1993;26:147-58.
43. Hohlfeld P, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989;115:765-9.
44. Ghidini A, Sitori M, Spelta A, Vergani P. Results of a preventive program for congenital toxoplasmosis. J Reprod Med 1991;36:270-3.
45. Pratlong F, Boulat P, Villena I, et al. Antenatal diagnosis of congenital toxoplasmosis: Evaluation of the biological parameters in a cohort of 286 patients. Br J Obstet Gynaecol 1996;103:552-7.
46. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: Systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999;318:1511-4.
47. Gilbert R, Gras L, Wallon M, et al. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: Retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001;30:1303-8.
48. Guerina N, Hsu H, Meissner H, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994;330:1858-63.
49. McAuley J, Boyer K, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis. The Chicago Collaborative Treatment Trial. Clin Infect Dis 1994;18:38-72.
50. Corey L, Spear PG. Infections with herpes simplex viruses. N Engl J Med 1986;314:686-91,749-5.
51. Armstrong GL, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the Unites States. Am J Epidemiol 2001;153:912-20.
52. Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am 1993;7:825-39.
53. Sugligoi B, Tchamgmena O, Sarmati L, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among adolescents and adults in northern Cameroon. Sex Transm Dis 2001;28:690-3.
54. Buchacz K, McFarland W, Hernandez M, et al. Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of Northern California. The Young Women's Survey Team. Sex Transm Dis 2000;27:393-400.
55. Patrick DM, Dawar M, Cook DA, et al. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001;28:424-8.
56. Sucato G, Celum C, Dithmer D, et al. Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents. Pediatr Infect Dis J 2001;20:422-6.
57. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
58. Baldwin S, Whitley RJ. Intrauterine herpes simplex virus infections. Teratology 1989;39:1-0.
59. Hutto C, Arvin A, Jacobs R, et al. Intrauterine herpes simplex virus infections. J Pediatr 1987;110:97-101.
60. Hoppen T, Eis-Hubinger AM, Schild RL, et al. Intrauterine herpes simplex virus infection. Klin Padiatr 2001;213:63-8.
61. Grose C. Congenital infections caused by varicella zoster virus and herpes simplex virus. Semin Pediatr Neurol 1994;1:43-9.
62. Jacobs RF. Neonatal herpes simplex virus infections. Sem Perinatol 1998;22:64-71.
63. Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. J Infect Dis 1996;174:1162-7.
64. Bale JF, Murph JR. Infections of the central nervous system of the newborn. Clin Perinatol 1997;24:787-806.
65. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2000;108:230-8.
66. Arvin A. Varicella-zoster virus. Clin Microbiol Rev 1996;9:361-81.
67. Brunell P. Varicella in pregnancy, the fetus, and the newborn: Problems in management. J Infect Dis 1992;166:42-7.
68. Pastuszak A, Levy M, Schick B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994;330:901-5.
69. Jones KL, Johnson KA, Chambers CA. Offspring of women infected with varicella during pregnancy: A prospective study. Teratology 1994;49:29-32.
70. Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 1986;14:1542-6.
71. Alkalay AL, Pomerance JJ, Rimoin DL. Fetal varicella syndrome. J Pediatr 1987;111:320-3.
72. Cuthbertson G, Weiner C, Giller R, et al. Clinical and laboratory observations: Prenatal diagnosis of second-trimester congenital varicella syndrome by virus-specific immunoglobulin M. J Pediatr 1987;111:592-5.
73. Isada NB, Paar DP, Johnson MP, et al. In utero diagnosis of congenital varicella zoster virus infection by chorionic villus sampling and polymerase chain reaction. Am J Obstet Gynecol 1991;165:1727-30.
74. American Academy of Pediatrics. Varicella zoster virus. In: Pickering LK, editor. 2000 Red book: report of the Committee on Infectious Diseases. 25th edition. Elk Grove Village, IL: American Academy of Pediatrics; 2000. p. 630-1.
75. Barton LL, Mets MB. Congenital lymphocytic choriomeningitis virus infection: Decade of rediscovery. Clin Infect Dis 2001;33:370-4.
76. Deibel R, Woodall JP, Becher WJ, Schryver GD. Lymphocytic choriomeningitis virus in man. Serologic evidence of association with pet hamsters. JAMA 1975;232:501-4.
77. Dykewicz CA, Dato VM, Fisher-Hoch SP, et al. Lymphocytic choriomeningitis outbreak associated with nude mice in a research institute. JAMA 1992;267:1349-53.
78. Childs JE, Glass GE, Ksiazek TG, et al. Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population. Am J Trop Med Hyg 1991;44:117-21.
79. Childs JE, Glass GE, Korch GW, et al. Lymphocytic choriomeningitis virus and house mouse (Mus musculus) distribution in urban Baltimore. Am J Trop Med Hyg 1992;47:27-34.
80. Park JY, Peters CJ, Rollin PE, et al. Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: Evidence of a decreased risk of infection. Am J Trop Med Hyg 1997;57:37-41.
81. Marie TJ, Saron MF. Seroprevalence of lymphocytic choriomeningitis virus in Nova Scotia. Am J Trop Med Hyg 1998;58:47-9.
82. Ambrosio AM, Feuillade MR, Gamboa GS, Maiztegui JL. Prevalence of lymphocytic choriomeningitis virus infection in a human population in Argentina. Am J Trop Med Hyg 1994;50:381-6.
83. Barton LL, Budd SC, Morfitt WS, et al. Congenital lymphocytic choriomeningitis virus infection in twins. Pediatr Infect Dis J 1993;12:942-6.
84. Wright R, Johnson D, Neumann M, et al. Congenital lymphocytic choriomeningitis virus syndrome: A disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics 1997;100:E9.
85. Schluter WW, Reer SE, Redd SC, Dykewicz CA. Changing epidemiology of congenital rubella syndrome in the United States. J Infect Dis 1998;178:636-41.
86. Cochi SL, Edmonds LE, Dyer K, et al. Congenital rubella syndrome in the United States, 1970-1985. Am J Epidemiol 1989;129:349-61.
87. Reef SE, Plotkin S, Cordero JF, et al. Preparing for elimination of congenital rubella syndrome (CRS). Summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000;31:85-95.
88. Centers for Disease Control and Prevention. Rubella outbreak: Arkansas, 1999. Morb Mortal Wkly Rep 2001;50:1137-39.
89. Gregg NM. Congenital cataract following German measles in the mother. Transactions of the Ophthalmologic Society of Australia 1941;3:35-41.
90. Dudgeon J. Congenital rubella. J Pediatr 1975;87:1078-86.
91. Ueda K, Nishida Y, Oshmia K, Shepard TH. Congenital rubella syndrome: Correlation of gestational age at time of maternal rubella with type of defect. J Pediatr 1979;94:763-5.
92. Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: Ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol 1993;77:358-63.
93. Souza I, Bale JF, Jr. The diagnosis of congenital infections: Contemporary strategies. J Child Neurol 1995;10:271-82.
94. American Academy of Pediatrics. Rubella. In: Pickering LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th Edition. Elk Grove Village, IL: American Academy of Pediatrics; 2000. p. 497.
95. Desmond MM, Fisher ES, Vorderman AL, et al. The longitudinal course of congenital rubella syndrome in nonretarded children. J Pediatr 1979;93:584-91.
96. Desmond MM, Wilson CW, Vorderman AL. The health and educational status of adolescents with the congenital rubella syndrome. Dev Med Child Neurol 1985;27:721-9.
97. Nakashima AK, Rolfs RT, Flock ML, Kilmarx P, Greenspan JR. Epidemiology of syphilis in the United States, 1941-1993. Sex Transm Dis 1996;23:16-23.
98. Centers for Disease Control and Prevention. Congenital syphilis - United States, 1998. Morb Mortal Wkly Rep 1999;48:757-61.
99. Sison CG, Ostrea EM, Reyes MP, Salari V. The resurgence of congenital syphilis: A cocaine-related problem. J Pediatr 1997;130:289-92.
100. Hollier LM, Cox SM. Syphilis. Semin Perinatol 1998;22:323-31.
101. Murph JR. Rubella and syphilis: Continuing causes of congenital infection in the 1990s. Semin Pediatr Neurol 1994;1:26-35.
102. Alexander JM, Sheffield JS, Sanchez PJ, Mayfield J, Wendel GD. Efficacy of treatment of syphilis in pregnancy. Obstet Gynecol 1999;93:5-8.
103. American Academy of Pediatrics. Syphilis. In: Pickering LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th Edition. Elk Grove Village, IL: American Academy of Pediatrics; 2000. p. 547-59.
104. Hulbert T. Congenital malaria in the United States: Report of a case and review. Clin Infect Dis 1992;14:922-6.
105. American Academy of Pediatrics. Syphilis. In: Pickering LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th Edition. Elk Grove Village, IL: American Academy of Pediatrics; 2000. p. 705-10.
106. Bittencourt AL. Congenital Chagas disease. Am J Dis Child 1975;130:97-103.
107. Wenger F. Venezuelan equine encephalitis. Teratology 1977;16:358-62.
108. Bale JF, Jr. Conditions mimicking congenital infections. Semin Pediatr Neurol 1994;1:63-70.